Humoral Immune Response of SARS‐CoV‐2–Infected Patients with Cancer: Influencing Factors and Mechanisms

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)–infected patients with cancer show worse outcomes compared with patients without cancer. The humoral immune response (HIR) of patients with cancer against SARS‐CoV‐2 is not well characterized. To better understand it, we conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Esperança‐Martins, Miguel, Gonçalves, Lisa, Soares‐Pinho, Inês, Gomes, Andreia, Serrano, Marta, Blankenhaus, Birte, Figueiredo‐Campos, Patrícia, Catarina‐Marques, Ana, Castro‐Barbosa, Ana, Cardoso, Ana, Antunes‐Meireles, Pedro, Atalaia‐Barbacena, Henrique, Gaspar, Pedro, Howell‐Monteiro, Patrícia, Pais‐de‐Lacerda, António, Mota, Catarina, Veldhoen, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Immuno‐Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242329/
https://www.ncbi.nlm.nih.gov/pubmed/34018280
http://dx.doi.org/10.1002/onco.13828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242329/
https://www.ncbi.nlm.nih.gov/pubmed/34018280
http://dx.doi.org/10.1002/onco.13828

Ejemplares similares